On August 4, 2025, Joby Aviation, Inc. (NYSE: JOBY), a California-based developer of electric vertical takeoff and landing (eVTOL) air taxis, announced a definitive agreement to acquire the passenger business of Blade Air Mobility, Inc. (NASDAQ: BLDE) for up to $125 million in cash or stock, with $35 million tied to performance milestones and key employee retention. The acquisition includes Blade’s U.S. and European operations, the Blade brand, and a network of 12 urban terminals, including premium facilities at John F. Kennedy International Airport, Newark Liberty Airport, and Manhattan’s West Side, East Side, and Wall Street. Blade, which flew over 50,000 passengers in 2024, offers helicopter and seaplane services for high-income clients, such as executives commuting to Manhattan or vacationers heading to the Hamptons.
The deal excludes Blade’s medical organ transport division, which will remain a separate public company rebranded as Strata Critical Medical but partner with Joby for medical transportation using eVTOLs. Joby’s CEO, JoeBen Bevirt, called the acquisition “strategically important” for supporting its commercial launch in Dubai in 2026 and global expansion, leveraging Blade’s decade of operational expertise and customer base. Blade’s CEO, Rob Wiesenthal, will lead the passenger business as a wholly-owned Joby subsidiary, ensuring continuity.
Why This Matters: Infrastructure and Market Access
Joby, founded in 2009 and backed by Toyota and Uber, is developing a quiet, all-electric air taxi designed to carry a pilot and four passengers up to 100 miles. With FAA Type Inspection flight testing slated for early 2026, the acquisition accelerates Joby’s market entry by providing immediate access to Blade’s infrastructure and high-value customers. Blade’s terminals in key markets like New York and Southern Europe (e.g., Nice to Monaco) align with Joby’s eVTOL range, reducing the need for costly vertiport development. @jobyaviation on X emphasized, “Blade gives us immediate market access and scale… with 12 high-value, urban terminals”.
The deal also integrates Joby’s ElevateOS software, acquired from Uber Elevate, into Blade’s operations, enhancing scheduling, customer analytics, and cost efficiency. Blade’s passenger segment, which generated $102 million in revenue and a $3.6 million profit in 2024, offers a proven model, with break-even helicopter flights from Manhattan to JFK requiring just two passengers. Analysts from Seeking Alpha suggest this could generate early cash flow for Joby’s hybrid operations before fully transitioning to eVTOLs.
Market Reaction and Financial Context
The announcement sparked significant market enthusiasm. Joby’s shares surged over 5% to $18.09 in pre-market trading, hitting a record high, while Blade’s stock jumped up to 30% to $4.88. The deal’s $125 million price tag, modest relative to Joby’s $14.4 billion market valuation, is seen as a cost-effective way to acquire infrastructure that could have cost hundreds of millions to build organically. Blade’s Q1 2025 revenue of $54.3 million and 42% year-over-year passenger growth suggest its passenger business is undervalued, with a potential enterprise value of $540 million at a 10x EV/Revenue multiple.
However, the deal includes risks. Joby’s $1.3 billion liquidity supports the acquisition, but $35 million in holdbacks tied to performance and retention underscores integration challenges. @wallstengine on X noted, “Joby will eventually swap” helicopters for eVTOLs, highlighting a transition phase that could strain operations if not managed carefully.
Industry Context and Competitive Landscape
The acquisition positions Joby ahead in the competitive advanced air mobility (AAM) sector, where rivals like Archer Aviation and Beta Technologies are also pursuing eVTOL certification. The global vertiport market is projected to grow from $0.4 billion in 2023 to $10.7 billion by 2030, underscoring the importance of Blade’s infrastructure. Joby’s progress, including test flights in Dubai and a manufacturing plant in Dayton, Ohio, aligns with its goal to launch commercial services in 2026. However, FAA certification delays and urban airspace regulations remain hurdles, as noted by Reuters.
Blade’s exit from the passenger business allows it to focus on its more profitable medical transport segment under Strata Critical Medical, with $7 million in annual cost savings expected. The partnership with Joby for medical eVTOL transport further diversifies Joby’s use cases. @OMillionaires on X called the deal a “$125 million acquisition of leading urban air mobility platform,” reflecting optimism about its impact.
Challenges and Future Outlook
The acquisition faces execution risks, including integrating Blade’s hospitality-driven culture with Joby’s tech-focused operations and maintaining customer loyalty during the transition to eVTOLs. FAA certification, a complex process, remains critical, with President Trump’s June 2025 executive order aimed at accelerating air taxi testing offering hope but no guarantee. Joby’s planned Dubai launch and global expansion hinge on successful integration and regulatory progress.
For investors, the deal could trigger a 30–50% stock re-rating if Joby achieves certification and scales Blade’s model internationally, per AINvest. Monitoring Joby’s Q3 2025 earnings and Blade’s performance milestones will be key. As @jobyaviation stated, “Together, we’ll be bringing more routes and quieter skies – to NYC, Monaco, and beyond”, signaling a transformative step for urban mobility.
